Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.38B |
| 2 |
Microsoft
MSFT
|
+$2.02B |
| 3 |
Apple
AAPL
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$861M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.67B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$1.49B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$867M |
| 4 |
Tesla
TSLA
|
+$550M |
| 5 |
GE Aerospace
GE
|
+$483M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Financials | 6.62% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.85% |
| 5 | Communication Services | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
3601
Crescent Biopharma
CBIO
$608M
| $371K | ﹤0.01% |
20,169
+19,546
| +3,137% | +$224K |
|
3602
Allot
ALLT
$373M
| $369K | ﹤0.01% |
55,468
-15,969
| -22% | -$141K |
|
|
ESPR
3603
DELISTED
Esperion Therapeutics
ESPR
| $366K | ﹤0.01% |
133,596
+12,502
| +10% | +$39.6K |
|
3604
Dimensional Emerging Markets High Profitability ETF
DEHP
$405M
| $366K | ﹤0.01% |
10,822
+2,675
| +33% | +$93.1K |
|
3605
Invesco DB Commodity Index Tracking Fund
DBC
$1.65B
| $365K | ﹤0.01% |
12,600
| – | – |
|
3606
Kyverna Therapeutics
KYTX
$455M
| $365K | ﹤0.01% |
42,260
+29,963
| +244% | +$250K |
|
3607
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.2B
| $363K | ﹤0.01% |
4,626
-1,268
| -22% | -$103K |
|
3608
Lindblad Expeditions
LIND
$1.95B
| $362K | ﹤0.01% |
20,946
+15,788
| +306% | +$280K |
|
3609
Diebold Nixdorf
DBD
$3.14B
| $361K | ﹤0.01% |
4,780
-8,137
| -63% | -$599K |
|
3610
National Healthcare
NHC
$3.61B
| $360K | ﹤0.01% |
2,257
-3,145
| -58% | -$483K |
|
3611
Stepan Co
SCL
$1.32B
| $356K | ﹤0.01% |
7,121
+1,128
| +19% | +$60.4K |
|
3612
iHeartMedia
IHRT
$537M
| $356K | ﹤0.01% |
121,864
+2,897
| +2% | +$9.59K |
|
|
BLSH
3613
Bullish
BLSH
$3.44B
| $356K | ﹤0.01% |
9,956
-2,773
| -22% | -$97.2K |
|
3614
Theravance Biopharma
TBPH
$875M
| $353K | ﹤0.01% |
21,747
+7,986
| +58% | +$141K |
|
3615
John Wiley & Sons Class A
WLY
$2.76B
| $353K | ﹤0.01% |
9,255
+795
| +9% | +$25.8K |
|
3616
Ingles Markets
IMKTA
$1.71B
| $351K | ﹤0.01% |
3,907
+2,053
| +111% | +$166K |
|
3617
Sinclair Inc
SBGI
$1.02B
| $350K | ﹤0.01% |
27,081
-21,036
| -44% | -$306K |
|
3618
Sylvamo
SLVM
$1.55B
| $349K | ﹤0.01% |
8,256
-1,775
| -18% | -$83.1K |
|
|
PPTA
3619
Perpetua Resources
PPTA
$2.18B
| $348K | ﹤0.01% |
12,403
-137,250
| -92% | -$4.15M |
|
|
HPP
3620
Hudson Pacific Properties
HPP
$765M
| $347K | ﹤0.01% |
58,788
+14,350
| +32% | +$110K |
|
3621
Village Super Market
VLGEA
$645M
| $346K | ﹤0.01% |
8,198
+6,125
| +295% | +$235K |
|
|
ORC
3622
Orchid Island Capital
ORC
$1.31B
| $346K | ﹤0.01% |
49,240
+21,747
| +79% | +$164K |
|
3623
PUT
Mercado Libre
MELI
$94.4B
| $346K | ﹤0.01% |
200
-1,600
| -89% | -$3.09M |
|
3624
iShares Morningstar Mid-Cap ETF
IMCB
$1.67B
| $345K | ﹤0.01% |
4,131
+30
| +0.7% | +$2.57K |
|
3625
Danaos Corp
DAC
$2.56B
| $343K | ﹤0.01% |
3,042
+1,742
| +134% | +$186K |
|
Similar funds
Citigroup's Q1 2026 Portfolio in Review
As of Q1 2026, Citigroup held 6,546 positions worth $235B, up 3.5% from $227B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citigroup deployed $16.9B of net new capital in Q1 2026, opening 553 new positions and adding to 2,742 existing holdings. Its largest new stake was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.67B trimmed.
- Citigroup's largest Q1 2026 buy was Oracle Corp Preferred Stock Series D: 1,846,042 shares worth $83.1M.
- Citigroup added most to NVIDIA in Q1 2026, an estimated $2.38B increase.
- Citigroup's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.67B.
- Citigroup fully exited CyberArk in Q1 2026, selling an estimated $241M.
- Citigroup's ten largest holdings make up 19% of its $235B portfolio in Q1 2026.
- Citigroup opened 553 new positions and closed 630 in Q1 2026.
- Citigroup's portfolio value rose 3.5% quarter-over-quarter to $235B.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.